Authorized purpose: Automatic Anatomy Recognition is cloud software that generates initial organ-at-risk contours from adult noncontrast CT of the head, neck, and thorax for transfer to a third-party radiation treatment-planning system; it has no contour-editing function and does not calculate dose or optimize plans.
Clinical role
Automatic initial organ-at-risk contouring independent of treatment modality, delivery method, or treatment intent.
Images and patients
Radiotherapy Planning Imaging · Head/Neck/Chest
Key limitation
Keep in mind: AAR is not for use on patients below 18 years of age, is intended only for head and neck and thoracic body regions, does not provide the capability to modify contours, and relies on third-party treatment planning systems to display and edit the contours.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Automatic Anatomy Recognition is cloud software that generates initial organ-at-risk contours from adult noncontrast CT of the head, neck, and thorax for transfer to a third-party radiation treatment-planning system; it has no contour-editing function and does not calculate dose or optimize plans.
Which images or clinical context are in scope?Modality: Radiotherapy Planning Imaging Anatomy or clinical context: Head/Neck/Chest Input: Adult DICOM 3.0 noncontrast CT studies of head and neck or thorax.
Who uses it?Intended users: Technicians and trained physicians involved in radiation-therapy planning.
What does the software produce?Output: DICOM contours for display and editing in a third-party treatment-planning system.
What is its most important limitation?Key limitation: AAR is not for use on patients below 18 years of age, is intended only for head and neck and thoracic body regions, does not provide the capability to modify contours, and relies on third-party treatment planning systems to display and edit the contours.
Clinical takeaway. Clinical role: Automatic Anatomy Recognition is cloud software that generates initial organ-at-risk contours from adult noncontrast CT of the head, neck, and thorax for transfer to a third-party radiation treatment-planning system; it has no contour-editing function and does not calculate dose or optimize plans.
Evidence takeaway. Evidence from the reviewed source record: K203610 reports unit, integration, system, and segmentation-performance testing using Dice and 95% Hausdorff distance but no public numerical results or clinical study. Developer-affiliated peer-reviewed AAR research provides broader algorithm context across 216 planning CTs and more than 2,600 objects, not exact-release clinical validation.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Automatic Anatomy Recognition is cloud software that generates initial organ-at-risk contours from adult noncontrast CT of the head, neck, and thorax for transfer to a third-party radiation treatment-planning system; it has no contour-editing function and does not calculate dose or optimize plans.
Exact FDA submission
Checked 2026-09-19
Clinical-use display mirrors the exact FDA-supported purpose reconciled from the decision-summary packet.
AAR is not for use on patients below 18 years of age, is intended only for head and neck and thoracic body regions, does not provide the capability to modify contours, and relies on third-party treatment planning systems to display and edit the contours.
Exact FDA submission
Checked 2026-09-19
The exact packet states the age, anatomic, contour-editing, and third-party-system boundaries but does not state the dossier's additional dose, registration, or plan-optimization exclusions.
K203610 reports unit, integration, system, and segmentation-performance testing using Dice and 95% Hausdorff distance but no public numerical results or clinical study. Developer-affiliated peer-reviewed AAR research provides broader algorithm context across 216 planning CTs and more than 2,600 objects, not exact-release clinical validation.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
K203610 reports unit, integration, system, and segmentation-performance testing using Dice and 95% Hausdorff distance but no public numerical results or clinical study. Developer-affiliated peer-reviewed AAR research provides broader algorithm context across 216 planning CTs and more than 2,600 objects, not exact-release clinical validation.
Sensitivity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or quantitative-biomarker function. Use the task-specific endpoints and tested population reported below.
Reported specificity
Not applicable
Not applicable
Not applicable
Checked 2026-09-03
Specificity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or quantitative-biomarker function. Use the task-specific endpoints and tested population reported below.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
K203610 FDA performance package for Automatic Anatomy Recognition (AAR)
DesignManufacturer nonclinical software and segmentation verification
PopulationAdult noncontrast head, neck, and thoracic radiotherapy-planning CT
Scopeexact submission
Tested versionAutomatic Anatomy Recognition release cleared in K203610
IndependenceSponsor or vendor study
K203610
Manufacturer evidence submitted for substantial equivalence; local clinical, technical, and workflow acceptance remains necessary.
No separate named-product Medicare payment was identified in the reviewed CMS radiation-oncology material. Evaluate net planning or delivery value within the radiotherapy service line.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Adult DICOM 3.0 noncontrast CT studies of head and neck or thorax.
Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: Cloud software on Linux with DICOM 3.0 CT input and TPS output; validate transfer, structure naming, supported anatomy, noncontrast protocols, editing, approval, and failed-case quarantine.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Unresolved route: DICOM contours for display and editing in a third-party treatment-planning system.
Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Cloud software on Linux with DICOM 3.0 CT input and TPS output; validate transfer, structure naming, supported anatomy, noncontrast protocols, editing, approval, and failed-case quarantine.
Only technicians and trained physicians involved in radiation-therapy planning. should operate or interpret the system. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: Not for patients younger than 18, abdomen or pelvis, contrast CT, dose calculation, registration, plan optimization, or contour editing. A third-party TPS must display and edit every contour.
Cloud software on Linux with DICOM 3.0 CT input and TPS output; validate transfer, structure naming, supported anatomy, noncontrast protocols, editing, approval, and failed-case quarantine.
exact submission · checked 2026-09-03
Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.
Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Not for patients younger than 18, abdomen or pelvis, contrast CT, dose calculation, registration, plan optimization, or contour editing. A third-party TPS must display and edit every contour.
exact submission · checked 2026-09-03
Define stop-use, escalation, rollback, and revalidation triggers before production use.
Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.
product family · checked 2026-09-03
Vendor productivity claims are scenario inputs, not guaranteed local savings.
Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: Not for patients younger than 18, abdomen or pelvis, contrast CT, dose calculation, registration, plan optimization, or contour editing. A third-party TPS must display and edit every contour.
exact submission · checked 2026-09-03
Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
27Fields reviewed
11Source classes checked
20Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains 20 PubMed and 0 ClinicalTrials.gov candidate records. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 20 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, peer reviewed publication, reimbursement policy, fda device recall, fda decision summary packet, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not publicly available - checked 2026-09-03 - Exact FDA submission
No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, enabled features, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not verified - checked 2026-09-03 - Exact FDA submission
Public materials reviewed for this batch do not establish the complete security posture for the exact release. Request data-flow, identity, audit, encryption, retention, support-access, vulnerability-management, backup, and incident-response evidence.
Authorized purpose: DeepBT Detector-Plus provides initial gross-tumor-volume contours on T1-weighted contrast-enhanced and optional T2-weighted MR images for radiation-treatment planning in adults with the labeled brain tumors.
Modality
Radiotherapy Planning Imaging
Anatomy
Brain tumors, including metastases, meningiomas, and acoustic neuromas
Authorized purpose: AI-Rad Companion Organs RT VA70 automatically contours predefined structures, including known diagnosed brain metastases, on DICOM CT and MR images for radiation therapy planning; qualified users must review, edit and accept contours in suitable planning or contouring software, and the device is not intended for diagnosis.
Modality
Radiotherapy Planning Imaging
Anatomy
Head/neck, thorax, abdomen, pelvis; MR brain and male pelvis
Authorized purpose: AutoContour Model RADAC V5 assists radiation treatment planners with contouring and reviewing structures in medical images for radiation therapy treatment planning. It produces initial machine-learning contours for user review and modification; it does not independently approve a contour or treatment plan.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.